• Home
  • Stock News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
Dividend Stocks Report
No Result
View All Result
Home Stock News

CDC shortens waiting period for Pfizer Covid boosters to 5 months

by
January 4, 2022
in Stock News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Related Posts

This telecom stock is set up to rally more than 20%, according to Morgan Stanley

China State-Owned Giants to Delist From US Amid Audit Spat

Fed expected to stick with hawkish rate hikes until data show further slowing in inflation

Oil prices are down, but energy companies’ earnings estimates keep rising — these stocks are cheap

UNITED STATES – OCTOBER 4: Hattie Pierce, 75, receives a Pfizer covid-19 vaccine booster shot from Dr. Tiffany Taliaferro at the Safeway on Capitol Hill in Washington, D.C., on Monday, October 4, 2021. (Photo By Tom Williams/CQ-Roll Call, Inc via Getty Images)
Tom Williams | CQ-Roll Call, Inc. | Getty Images

People who received the Pfizer and BioNTech Covid vaccine can now get a booster shot five months after their second dose, a month sooner than the federal government’s previous guidance.

The U.S. Centers for Disease Control and Prevention on Tuesday updated its recommended waiting period for people who completed their primary Covid-19 vaccination series with Pfizer’s shots.

People who received the Moderna vaccine must still wait at least six months after their second dose before getting a booster, while people who received the Johnson & Johnson must wait at least two months after their first shot before getting a booster.

The CDC also now recommends that children ages 5 to 11 who have moderate or severely compromised immune systems receive a third shot as part of their primary vaccination series 28 days after their second dose. Currently, Pfizer is the only recommended and authorized vaccine for kids in that age group.

The CDC’s new recommendations come a day after the Food and Drug Administration authorized Pfizer boosters at 5 months and third shots for kids 5 to 11 with compromised immune systems.

“Following the FDA’s authorizations, today’s recommendations ensure people are able to get a boost of protection in the face of Omicron and increasing cases across the country, and ensure that the most vulnerable children can get an additional dose to optimize protection against COVID-19,” CDC Director Rochelle Walensky said in a statement.

“If you or your children are eligible for a third dose or a booster, please go out and get one as soon as you can,” Walensky said.

The CDC’s vaccine advisory committee has scheduled a meeting Wednesday to review the FDA’s recommendation to distribute boosters to all adolescents aged 12 to 15.

This is breaking news. Please check back for updates.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:

FDA expands Pfizer booster eligibility to kids ages 12 to 15

U.S. considers recommending negative Covid test before people end isolation period, Fauci says

Biden says Covid surge needs to be solved at state level, vows full federal support

Fauci says U.S. should consider vaccine mandate for domestic air travel

New studies suggest omicron has lower hospitalization risk and is milder than other variants

Next Post

Top Materials Stocks for January 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

Popular Posts

Stock News

This telecom stock is set up to rally more than 20%, according to Morgan Stanley

by
August 12, 2022
0

Ciena Corporation is set up for solid earnings in the coming quarters, which could add meaningful gains to shares of...

Read more

This telecom stock is set up to rally more than 20%, according to Morgan Stanley

China State-Owned Giants to Delist From US Amid Audit Spat

Fed expected to stick with hawkish rate hikes until data show further slowing in inflation

Oil prices are down, but energy companies’ earnings estimates keep rising — these stocks are cheap

GLAAD CEO swears by this ‘controversial’ career move

Semiconductor companies have split into two groups — the resilient and the risky

Load More

All rights reserved by www.dividendstocksreport.net

  • Home
  • Stock News
  • Privacy Policy
  • Email Whitelisting
No Result
View All Result
  • Home
  • Stock News
  • Privacy Policy
  • Email Whitelisting

© 2022 JNews - Premium WordPress news & magazine theme by Jegtheme.